CARDIO DIAGNOSTICS HOLDGS IN *W EXP 10/25/202
CARDIO DIAGNOSTICS HOLDGS IN *W EXP 10/25/202 is a security (CUSIP 14159C111) tracked across SEC portfolio filings. 10 institutional managers reported $128K on Form 13F as of 2026-06-30; 1 registered fund positions totaling $231 via N-PORT as of 2026-04-30.
Summary
- Issuer: CARDIO DIAGNOSTICS HOLDGS IN
- Class: *W EXP 10/25/202
- CUSIP: 14159C111
- Asset category: DE
- 13F holders: 10
- 13F value: $128K
- 13F period: 2026-06-30
- N-PORT fund positions: 1
- N-PORT value: $231
- N-PORT report: 2026-04-30
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| BOOTHBAY FUND MANAGEMENT, LLC | NEW YORK, NY | $118K | 60,540 |
| Saba Capital Management, L.P. | NEW YORK, NY | $3K | 199,839 |
| Clear Street Group Inc. | NEW YORK, NY | $1K | 82,342 |
| CLEAR STREET LLC | NEW YORK, NY | $1K | 82,742 |
| ATW SPAC MANAGEMENT LLC | NEW YORK, NY | $1K | 60,540 |
| Context Capital Management, LLC | LAJOLLA, CA | $1K | 81,500 |
| D. E. Shaw & Co., Inc. | New York, NY | $1K | 74,822 |
| UBS Group AG | Zurich, V8 | $89 | 5,561 |
| Virtu Financial LLC | New York, NY | $1 | 30,788 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |
Top fund holders (N-PORT)
| Fund | Registrant | Value | % of fund |
|---|
| Saba Capital Income & Opportunities Fund | Saba Capital Income & Opportunities Fund | $231 | 0.01% |
More